drugset / Trial / NCT04595318
Varenicline for Co-occurring Cannabis and Tobacco Use
Phase 4
Completed
7 enrolled
Albert Einstein College of Medicine
National Institute of General Medical Sciences (NIGMS) · collabNational Institute on Drug Abuse (NIDA) · collab
RandomizedCrossoverOpen-labelTreatment
Summary
Pilot, eight week, open-label, within-subject cross over trial of four weeks of standard clinical care (SCC) in an outpatient substance use disorder treatment program and four weeks of SCC and varenicline among current and former tobacco smokers with frequent cannabis use.
Timeline
- Start
- 2015-01
- Primary completion
- 2015-07
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Varenicline | Small molecule | 1 mg | — |